Why doctors still prescribe sertraline instead of the antidepressant you're looking for

Sertraline and Prozac: why SSRIs are still being prescribed

A month on 100 mg of sertraline. Dizziness, trouble walking in a straight line, and the feeling that the pill did nothing except cause "night-time brain zaps and discomfort." The person describing it never went back to the doctor. It's the kind of experience that fuels the suspicion that psychiatric pharmacology has been stuck in the 1980s: fluoxetine and sertraline as the almost automatic first response, when the patient was hoping for something more refined than a general flattening of the nervous system.

The complaint has a technical name and is well documented: emotional blunting. It's a common side effect of SSRIs —fluoxetine, sertraline, escitalopram— and when it appears, it's reason enough to raise it with your doctor. The problem isn't that it exists, but that patients are expected to live with it as if it were the inevitable toll of being on medication.

Why are SSRIs still the first choice?

Because in clinical trials, antidepressants from later generations do not, overall, prove clearly more effective than SSRIs. What changes is the side effect profile. Add to that the mundane factors: decades of accumulated experience, low cost, and a reasonable safety margin. An old, boring drug is a drug the healthcare system knows how to handle.

The argument holds up until a specific patient ends up feeling flat. That's where alternatives that work through different mechanisms come in: bupropion, which is not serotonergic and causes less blunting and fewer sensual side effects, or vortioxetine. They're not a miracle cure or a gateway to a new world, but they exist and aren't always mentioned at the first appointment.

The problem of doses changed without warning

Psychiatric medication works like a constant battle. After three months, the effect can change and leave the patient struggling. What's most frustrating isn't the drug itself, but the blind adjusting: changing doses "just to see how it goes," with the trial failing like a fairground shotgun. Pregabalin comes up in these conversations as the wildcard that, depending on the diagnosis of the day, cures everything.

Some take the criticism into the realm of diet, arguing that a diet based on meat and fish would make psychiatric pills unnecessary. It's a claim that circulates without clinical backing within the discussion itself, and it should be treated as what it is: just another opinion in a conversation where distrust of the official prescription pad comes before the evidence.

The awkward comparison with stimulants

The contrast that closes the circle: stimulants suit almost everyone, while millions of people endure Prozac or sertraline with effects ranging from dizziness to loss of sensual drive. The observation has rhetorical appeal and little pharmacological basis, but it points to something real: the perception that the system rewards what works fast and punishes those who ask why they've been taking the same thing for four decades.

The question left hanging isn't which is the perfect antidepressant. It's how many patients are taking an SSRI without anyone having explained that other options exist, and how many quit on their own without telling their doctor.